Sunesis Pharmaceuticals, Inc. ( SNSS ) was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock is now up 26.31% since Jul 17.
None of the estimates for this stock were revised over the past 7 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Sunesis Pharmaceuticals carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.
Some better-ranked stocks in the healthcare sector include Actelion Ltd. ( ALIOF ), Cytokinetics, Incorporated ( CYTK ) and Heska Corporation ( HSKA ). All of these stocks carry a Zacks Rank #1 (Strong Buy).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.